TALPHERA, INC. — Director's Dealing 2023

Mar 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2023-03-03

Reporting Person: ASADORIAN RAFFI (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-03	Common Stock	F	510	$1.31	Disposed	22081	Direct

Footnotes

F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.